Quick Answer
Krystal Biotech, Inc. reported Total Revenue of $389.13 million for fiscal year 2025.
Krystal Biotech, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $389.13M | +33.9% |
| 2024 | $290.51M | +473.0% |
| 2023 | $50.70M | — |
| 2022 | $0.00 | — |
| 2021 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $97.80M | +16.6% | +1.8% |
| June 30, 2025 | $96.04M | +36.6% | +8.9% |
| March 31, 2025 | $88.18M | +94.9% | +5.2% |
| September 30, 2024 | $83.84M | +879.9% | +19.3% |
| June 30, 2024 | $70.28M | — | +55.3% |
| March 31, 2024 | $45.25M | — | +428.9% |
| September 30, 2023 | $8.56M | — | — |
| June 30, 2023 | $0.00 | — | — |
- Krystal Biotech, Inc. showed an increase of +33.9% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Krystal Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: